Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of Multisystem Inflammatory Syndrome in Children
Andrew McArdle, Ortensia Vito, Harsita Patel, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 1, pp. 11-22
Open Access | Times Cited: 308

Showing 1-25 of 308 citing articles:

A guide to immunotherapy for COVID-19
Frank L. van de Veerdonk, Evangelos J. Giamarellos‐Bourboulis, Peter Pickkers, et al.
Nature Medicine (2022) Vol. 28, Iss. 1, pp. 39-50
Open Access | Times Cited: 276
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3
Lauren A. Henderson, Scott W. Canna, Kevin G. Friedman, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 4
Open Access | Times Cited: 238
Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison
Chetan Sharma, Madhusudan Ganigara, Caroline Galeotti, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 12, pp. 731-748
Open Access | Times Cited: 209
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19
Keith Sacco, Riccardo Castagnoli, Svetlana Vakkilainen, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1050-1062
Open Access | Times Cited: 193
Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination
Dongngan T. Truong, Audrey Dionne, Juan Carlos Muniz, et al.
Circulation (2021) Vol. 145, Iss. 5, pp. 345-356
Open Access | Times Cited: 158
COVID‐19 in children. II: Pathogenesis, disease spectrum and management
Annaleise R. Howard‐Jones, David Burgner, Nigel Crawford, et al.
Journal of Paediatrics and Child Health (2021) Vol. 58, Iss. 1, pp. 46-53
Open Access | Times Cited: 104
SARS-CoV-2 infections in children: Understanding diverse outcomes
Petter Brodin
Immunity (2022) Vol. 55, Iss. 2, pp. 201-209
Open Access | Times Cited: 103
IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting
Lori Broderick, Hal M. Hoffman
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 8, pp. 448-463
Open Access | Times Cited: 97
Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management
Eleanor J. Molloy, Natasha Nakra, Chris Gale, et al.
Pediatric Research (2022) Vol. 93, Iss. 6, pp. 1499-1508
Open Access | Times Cited: 74
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
Saul N. Faust, Richard Haynes, Christine E. Jones, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 3, pp. 190-200
Open Access | Times Cited: 14
Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19
Eveline Y. Wu, Michael J. Campbell
Current Cardiology Reports (2021) Vol. 23, Iss. 11
Open Access | Times Cited: 91
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
Levi Hoste, Lisa Roels, Leslie Naesens, et al.
The Journal of Experimental Medicine (2021) Vol. 219, Iss. 2
Open Access | Times Cited: 74
Treatment of MIS-C in Children and Adolescents
Sanaa Mahmoud, Mostafa El-Kalliny, Alyaa Kotby, et al.
Current Pediatrics Reports (2022) Vol. 10, Iss. 1, pp. 1-10
Open Access | Times Cited: 65
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 65
Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children
Laura A. Vella, Anne H. Rowley
Current Pediatrics Reports (2021) Vol. 9, Iss. 4, pp. 83-92
Open Access | Times Cited: 62
Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection — United States
Michael Melgar, Ellen H. Lee, Allison D. Miller, et al.
MMWR Recommendations and Reports (2022) Vol. 71, Iss. 4, pp. 1-14
Open Access | Times Cited: 61
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome
Hassan Abolhassani, Nils Landegren, Paul Bastard, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 3, pp. 471-483
Open Access | Times Cited: 60
An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2
Audrey Dionne, Mary Beth F. Son, Adrienne G. Randolph
The Pediatric Infectious Disease Journal (2021) Vol. 41, Iss. 1, pp. e6-e9
Open Access | Times Cited: 60
SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association
Pei‐Ni Jone, Anitha S. John, Matthew E. Oster, et al.
Circulation (2022) Vol. 145, Iss. 19
Open Access | Times Cited: 57
Paediatric critical COVID-19 and mortality in a multinational prospective cohort
Sebastián González‐Dambrauskas, Pablo Vásquez‐Hoyos, Anna Camporesi, et al.
The Lancet Regional Health - Americas (2022) Vol. 12, pp. 100272-100272
Open Access | Times Cited: 52
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
Lorenza Romani, Federica Del Chierico, Gabriele Macari, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 49
Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children
D. Sofia Villacis-Nunez, Kaitlin Jones, Aysha Jabbar, et al.
JAMA Pediatrics (2022) Vol. 176, Iss. 6, pp. 576-576
Open Access | Times Cited: 45
Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations
Alanood S. Algarni, Njoud M. Alamri, Noor Z. Khayat, et al.
World Journal of Pediatrics (2022) Vol. 18, Iss. 2, pp. 83-90
Open Access | Times Cited: 42
Multisystem Inflammatory Syndrome in Neonates Born to Mothers with SARS-CoV-2 Infection (MIS-N) and in Neonates and Infants Younger Than 6 Months with Acquired COVID-19 (MIS-C): A Systematic Review
Domenico Umberto De Rose, Flaminia Pugnaloni, Monica Calì, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 750-750
Open Access | Times Cited: 39
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study
Samuel Channon‐Wells, Ortensia Vito, Andrew McArdle, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 4, pp. e184-e199
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top